![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
PERSPECTIVES IN PHARMACOLOGY
Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland
Human plasma contains several catechols, including the catecholamines norepinephrine, epinephrine, and dopamine, their precursor, L-3,4-dihydroxyphenylalanine (L-DOPA), and their deaminated metabolites, dihydroxyphenylglycol, the main neuronal metabolite of norepinephrine, and dihydroxyphenylacetic acid, a deaminated metabolite of dopamine. Products of metabolism of catechols include 3-methoxytyrosine (from L-DOPA), homovanillic acid and dopamine sulfate (from dopamine), normetanephrine, vanillylmandelic acid, and methoxyhydroxyphenylglycol (from norepinephrine), and metanephrine (from epinephrine). Plasma levels of catechols and their metabolites have related but distinct sources and therefore reflect different functions of catecholamine systems. This article provides an update about plasma levels of catechols and their metabolites and the relevance of those levels to some issues in human health and disease.
Address correspondence to: Dr. David S. Goldstein, Bldg. 10, Rm. 6N252, NINDS, NIH, 10 Center Drive, MSC-1620, Bethesda, MD 20892-1620. E-mail: goldsteind{at}ninds.nih.gov
This article has been cited by other articles:
|
|
 |
|
  S. Griffin and B. Logue Takotsubo Cardiomyopathy: A Nurse's Guide Crit. Care Nurse, October 1, 2009; 29(5): 32 - 42. [Full Text] [PDF]
|
|
|
|
 |
|
 W. H. A. de Jong, G. Eisenhofer, W. J. Post, F. A. J. Muskiet, E. G. E. de Vries, and I. P. Kema Dietary Influences on Plasma and Urinary Metanephrines: Implications for Diagnosis of Catecholamine-Producing Tumors J. Clin. Endocrinol. Metab., August 1, 2009; 94(8): 2841 - 2849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. ZOGRAFOS, F. ZAGOURI, T. N. SERGENTANIS, G. GIANNAKOPOULOU, X. PROVATOPOULOU, E. KALOGERA, C. PAPADIMITRIOU, G. FILIPPAKIS, A. SAGKRIOTIS, J. BRAMIS, et al. Excisional Breast Biopsy Under Local Anesthesia: Stress-related Neuroendocrine, Metabolic and Immune Reactions During the Procedure In Vivo, July 1, 2009; 23(4): 649 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Chakroborty, C. Sarkar, B. Basu, P. S. Dasgupta, and S. Basu Catecholamines Regulate Tumor Angiogenesis Cancer Res., May 1, 2009; 69(9): 3727 - 3730. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Maguire, W. A. E. Parker, S. M. Foord, T. I. Bonner, R. R. Neubig, and A. P. Davenport International Union of Pharmacology. LXXII. Recommendations for Trace Amine Receptor Nomenclature Pharmacol. Rev., March 1, 2009; 61(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Goldstein and Y. Sharabi Neurogenic Orthostatic Hypotension: A Pathophysiological Approach Circulation, January 6, 2009; 119(1): 139 - 146. [Full Text] [PDF]
|
|
|
|
|
|
Y. J. Akashi, D. S. Goldstein, G. Barbaro, and T. Ueyama Takotsubo Cardiomyopathy: A New Form of Acute, Reversible Heart Failure Circulation, December 16, 2008; 118(25): 2754 - 2762. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Eisenhofer, T.-T. Huynh, A. Elkahloun, J. C. Morris, G. Bratslavsky, W. M. Linehan, Z. Zhuang, B. M. Balgley, C. S. Lee, M. Mannelli, et al. Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma Am J Physiol Endocrinol Metab, November 1, 2008; 295(5): E1223 - E1233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Goldstein Genotype and Vascular Phenotype Linked by Catecholamine Systems Circulation, January 29, 2008; 117(4): 458 - 461. [Full Text] [PDF]
|
|
|
|
 |
|
 D. S. Goldstein, R. Imrich, E. Peckham, C. Holmes, G. Lopez, C. Crews, J. Hardy, A. Singleton, and M. Hallett Neurocirculatory and nigrostriatal abnormalities in Parkinson disease from LRRK2 mutation Neurology, October 16, 2007; 69(16): 1580 - 1584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Garland, S. R. Raj, B. K. Black, P. A. Harris, and D. Robertson The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome Neurology, August 21, 2007; 69(8): 790 - 798. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. B. Wyller, K. Godang, L. Morkrid, J. P. Saul, E. Thaulow, and L. Walloe Abnormal Thermoregulatory Responses in Adolescents With Chronic Fatigue Syndrome: Relation to Clinical Symptoms Pediatrics, July 1, 2007; 120(1): e129 - e137. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rao, G. Wen, J. R. Gayen, M. Das, S. M. Vaingankar, B. K. Rana, M. Mahata, B. P. Kennedy, R. M. Salem, M. Stridsberg, et al. Catecholamine Release-Inhibitory Peptide Catestatin (Chromogranin A352-372): Naturally Occurring Amino Acid Variant Gly364Ser Causes Profound Changes in Human Autonomic Activity and Alters Risk for Hypertension Circulation, May 1, 2007; 115(17): 2271 - 2281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Chamorro, X. Urra, and A. M. Planas Infection After Acute Ischemic Stroke: A Manifestation of Brain-Induced Immunodepression Stroke, March 1, 2007; 38(3): 1097 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J Giltay, K. H Kho, B. A Blansjaar, M. M Verbeek, P B. H Geurtz, J. M Geleijnse, and L. J G Gooren The sex difference of plasma homovanillic acid is unaffected by cross-sex hormone administration in transsexual subjects J. Endocrinol., October 1, 2005; 187(1): 109 - 116. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Desaulniers, G.-H. Xiao, K. Leingartner, I. Chu, B. Musicki, and B. K. Tsang Comparisons of Brain, Uterus, and Liver mRNA Expression for Cytochrome P450s, DNA Methyltransferase-1, and Catechol-O-Methyltransferase in Prepubertal Female Sprague-Dawley Rats Exposed to a Mixture of Aryl Hydrocarbon Receptor Agonists Toxicol. Sci., July 1, 2005; 86(1): 175 - 184. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Taneja, A. Diedrich, B. K. Black, D. W. Byrne, S. Y. Paranjape, and D. Robertson Modafinil Elicits Sympathomedullary Activation Hypertension, April 1, 2005; 45(4): 612 - 618. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Goldstein, B. Eldadah, C. Holmes, S. Pechnik, J. Moak, and Y. Sharabi Neurocirculatory Abnormalities in Chronic Orthostatic Intolerance Circulation, February 22, 2005; 111(7): 839 - 845. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. S. Wittstein, D. R. Thiemann, J. A.C. Lima, K. L. Baughman, S. P. Schulman, G. Gerstenblith, K. C. Wu, J. J. Rade, T. J. Bivalacqua, and H. C. Champion Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress N. Engl. J. Med., February 10, 2005; 352(6): 539 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Imrich, J Rovensky, F Malis, M Zlnay, Z Killinger, R Kvetnansky, M Huckova, M Vigas, L Macho, and J Koska Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycaemia in premenopausal women with rheumatoid arthritis Ann Rheum Dis, February 1, 2005; 64(2): 202 - 206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Jackson, F. L. R. Williams, A. Burchell, M. W. H. Coughtrie, and R. Hume Plasma Catecholamines and the Counterregulatory Responses to Hypoglycemia in Infants: A Critical Role for Epinephrine and Cortisol J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6251 - 6256. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. E. de Galan, C. J. Tack, J. J. Willemsen, C. G. J. Sweep, P. Smits, and J. W. M. Lenders Plasma Metanephrine Levels Are Decreased in Type 1 Diabetic Patients with a Severely Impaired Epinephrine Response to Hypoglycemia, Indicating Reduced Adrenomedullary Stores of Epinephrine J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2057 - 2061. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
